Diabetes drug Liraglutide could reverse damage caused by Alzheimers disease

CHICAGO: Researchers are recruiting people with early Alzheimers disease for a trial of a diabetes drug. If successful, the drug could reverse the damage caused by Alzheimer’s disease.

The study could lead to the biggest breakthrough in the treatment of dementia for over decades…

Full story covered in the Dementia Business Weekly.

Leave a Reply

Your email address will not be published. Required fields are marked *


*


*SPAM CHECK Time limit is exhausted. Please reload the CAPTCHA.